Editorial

Preventing ventilator associated pneumonia

BMJ 2007; 334 doi: 10.1136/bmj.39185.380405.BE (Published 26 April 2007)
Cite this as: BMJ 2007;334:861

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Christian Brun-Buisson, professor
  1. Service de Réanimation Médicale, Centre Hospitalier Universitaire Henri Mondor, AP-HP, Université Paris 12, Créteil, France
  1. Christian.brun-buisson{at}hmn.aphp.fr

    Oral antiseptic agents should be part of a multifaceted preventive care package

    Pneumonia occurring during mechanical ventilation (ventilator associated pneumonia) is the most common infection acquired by patients in intensive care. Reported rates range from 9% to 67% and 4.4 to 15.7 cases per 1000 ventilator days.1 In this week's BMJ, a systematic review by Chan and colleagues2 assesses the effect of oral decontamination with antiseptics on ventilator associated pneumonia and mortality in mechanically ventilated adults.

    Ventilator associated pneumonia prolongs lengths of stay in intensive care and hospital, and it increases costs of care and possibly increases mortality.3 4 The prevention of this infection is therefore a high priority for infection control in intensive care.5

    Preventive procedures deal with three broad areas: prevention of cross transmission; upper digestive tract colonisation and the risk of inhalation; and maintenance and care of the artificial and natural airways.5 6 7 Because the oropharynx and upper intestinal tract are the major sources of organisms causing pneumonia in intensive care, they would appear …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular